Catena Biosciences

Brief Description

Cantena Biosciences uncovered a novel protein conjugation method that can bring breakthroughs in biological therapeutics, autoimmune disorders, and vaccine development.

Catena’s technology allows the attachment of any two proteins together faster and more selectively than any competing method by attaching the natural amino acids tyrosine and cysteine. Since the company's platform uses only naturally occurring amino acids, it is more widely applicable than competing technologies and can be used to create complicated constructs far beyond the capability of genetic fusions or chemical attachment found in the industry today.


Marco Lobba

Tech Category

  • Medical Therapeutics

Join the IPIRA Mailing List




Accessibility | Nondiscrimination | Privacy